Page last updated: 2024-09-04

edotreotide and Medulloblastoma

edotreotide has been researched along with Medulloblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avoledo, P; Beutler, D; Kühne, T; Mäcke, HR; Merlo, A; Müller-Brand, J; Reubi, JC	1

Other Studies

1 other study(ies) available for edotreotide and Medulloblastoma

Article	Year
Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy. Cancer, 2005, Feb-15, Volume: 103, Issue:4 Topics: Antineoplastic Agents; Brachytherapy; Cauda Equina; Cerebellar Neoplasms; Child; Disease-Free Survival; Humans; Immunohistochemistry; Injections, Spinal; Male; Medulloblastoma; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin	2005

Article

Year

Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy.

Cancer, 2005, Feb-15, Volume: 103, Issue:4

Topics: Antineoplastic Agents; Brachytherapy; Cauda Equina; Cerebellar Neoplasms; Child; Disease-Free Survival; Humans; Immunohistochemistry; Injections, Spinal; Male; Medulloblastoma; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin

2005